On the first day, many patients report minimal immediate effects
The results are expected by the end of 2025, and if they confirm what the observational studies are suggesting, it could open up a whole new use case for GLP-1 medications in neurology
Vitamin C helps keep glutathione in its active state, which may enhance the antioxidant effects
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist GLP2 in patients with type 2 diabetes (SURPASS-1): A double-blind, randomised, phase 3 trial
Their use is not prohibited by WADA, however some sporting authorities ban the use of hypoxic chambers during competitions under their sport rules
An injection places a known, standardized dose directly where the body can use it, which is why prescription GLP-1 therapy is delivered that way and is backed by clinical trials and safety monitoring